Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Oral Dosing of the Novel Proteasome Inhibitor CEP-18770 Shows Marked Anti-Myeloma Effects in SCID-Hu Models of Multiple Myeloma.

Eric Sanchez, Mingjie Li, Jeffrey A Steinberg, Cathy S Wang, Jing Shen, Benjamin Bonavida, PhD, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 1840.

https://doi.org/10.1182/blood.V114.22.1840.1840

Published: 2009

Journal Articles

Alpha Lipoic Acid (ALA) Inhibits the Anti-Myeloma Effects of Bortezomib.

Jeffrey A Steinberg, Jing Shen, Eric Sanchez, Haiming Chen, MD, PhD, Zhi-Wei Li, PhD, Jacqueline Hilger, MS, James R. Berenson, MD

Blood (2009) 114 (22): 3832.

https://doi.org/10.1182/blood.V114.22.3832.3832

Published: 2009

Journal Articles

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

Zhi-Wei Li, PhD, Mengyin Hu, Crystal Leung, Jeffrey A Steinberg, Jing Shen, Mingjie Li, Cathy S Wang, Eric Sanchez, Albert Bowers, Thomas Greshock, Kenneth Miller, Tenaya Newkirk, Nathan West, James E. Bradner, MD, Robert M Williams, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 4925.

https://doi.org/10.1182/blood.V114.22.4925.4925

Published: 2009

Journal Articles

CC102528: A Novel Histone Deacetylase Inhibitor in the Hydroxamate Family Demonstrates Potent Anti-Myeloma Activity.

Zhi-Wei Li, PhD, Crystal Leung, Mengyin Hu, Jinbao Xiang, Chao Jiang, Jeffrey A Steinberg, Jing Shen, Mingjie Li, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, Xu Bai, James R. Berenson, MD

Blood (2009) 114 (22): 4927.

https://doi.org/10.1182/blood.V114.22.4927.4927

Published: 2009

Journal Articles

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jennifer Finefield, Crystal Leung, Mengyin Hu, Jing Shen, Mingjie Li, Cathy S Wang, Jeffrey A Steinberg, Eric Sanchez, Haiming Chen, MD, PhD, Robert M Williams, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 1851.

https://doi.org/10.1182/blood.V114.22.1851.1851

Published: 2009

Journal Articles

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jing Shen, Michael Share, Mingjie Li, Cathy S Wang, Eric Sanchez, Jeffrey A Steinberg, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 2727.

https://doi.org/10.1182/blood.V112.11.2727.2727

Published: 2008

Journal Articles

In Vivo Anti-Tumor Efficacy of Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Multiple Myeloma

Eric Sanchez, Jeffrey A Steinberg, Mingjie Li, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, Steven R. Deitcher, MD, Anne E Hagey, MD, James R. Berenson, MD

Blood (2008) 112 (11): 2760.

https://doi.org/10.1182/blood.V112.11.2760.2760

Published: 2008

Journal Articles

Characterization of Cancer Stem Cells in Multiple Myeloma

Haiming Chen, MD, PhD, Mingjie Li, Eric Sanchez, Cathy S Wang, Ariana M Berenson, Jennifer Li, Jeffrey A Steinberg, James Wang, Jing Shen, Zhi-Wei Li, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 495.

https://doi.org/10.1182/blood.V112.11.495.495

Published: 2008

Journal Articles

A Novel Method for Screening Anti-Angiogenic Compounds: The Chorionicallantoic Membrane (CAM)/Feather Bud (FB) Assay.

Haiming Chen, MD, PhD, Cathy S Wang, Mingjie Li, Eric Sanchez, Jennifer Li, Ariana M Berenson, Jeffrey A Steinberg, Hang Chen, Jing Shen, Zhi-Wei Li, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 1896.

https://doi.org/10.1182/blood.V112.11.1896.1896

Published: 2008

Journal Articles

The Novel Proteasome Inhibitor CEP-18770 Inhibits Myeloma Tumor Growth In Vitro and In Vivo and Enhances the Anti-MM Effects of Melphalan

Eric SancheZ, Richard A Campbell, BS, Jeffrey A Steinberg, Mingjie Li, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2008) 112 (11): 843.

https://doi.org/10.1182/blood.V112.11.843.843

Published: 2008

NARROW

Oral Dosing of the Novel Proteasome Inhibitor CEP-18770 Shows Marked Anti-Myeloma Effects in SCID-Hu Models of Multiple Myeloma.

Alpha Lipoic Acid (ALA) Inhibits the Anti-Myeloma Effects of Bortezomib.

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

CC102528: A Novel Histone Deacetylase Inhibitor in the Hydroxamate Family Demonstrates Potent Anti-Myeloma Activity.

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

A Novel Targeted Therapeutic Approach to Multiple Myeloma Using Tumor Specific Anti-Sense RNA Sequences

In Vivo Anti-Tumor Efficacy of Vincristine Sulfate Liposomes Injection (VSLI, Marqibo®) in Multiple Myeloma

Characterization of Cancer Stem Cells in Multiple Myeloma

A Novel Method for Screening Anti-Angiogenic Compounds: The Chorionicallantoic Membrane (CAM)/Feather Bud (FB) Assay.

The Novel Proteasome Inhibitor CEP-18770 Inhibits Myeloma Tumor Growth In Vitro and In Vivo and Enhances the Anti-MM Effects of Melphalan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only